A troubled Sun Pharma plant fails yet another FDA inspection

Taking stock of the drug industry, from the lab to the medicine chest

July 15, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | A troubled Sun Pharma plant fails yet another FDA inspection The problems at Sun's Halol facility are only the latest in a series of quality control issues facing the generic manufacturer. By Ed Silverman STAT+ | ViiV expands licensing deal for its HIV drug in low-income countries UNAIDS Executive Director Winnie Byanyima cautioned that "more work will be needed to... achieve full price transparency" By Ed Silverman STAT+ | Opinion: The end of animal testing? Transitioning to models is promising — but no silver bullet Sponsors, technology companies, consulting companies, and regulators all need to support creating alternatives to animal testing. By Amin Rostami-Hodjegan Adobe STAT+ | Kailera drug shows notable weight loss in China trial Today's biotech news features Kailera's drug showing notable weight loss in China trial, challenges phasing out animal testing, etc. By Elaine Chen STAT+ | A well-placed biotech investor says U.S. policies are straining life sciences startups Entrepreneur Johannes Fruehauf, co-founder of LabCentral and BioLabs, believes that more disruption is coming. By Allison DeAngelis Opinion: I worked for 20 years for the HHS office that safeguarded people in research studies. DOGE gutted it The OHRP staff with substantive expertise, experience, and institutional memory of regulatory policy are almost all gone. By Ivor Pritchard

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser